Agenovir Corporation
VerifiedAgenovir is developing novel antiviral therapeutics for diseases associated with viral reservoirs.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$42—64m (Dealroom.co estimates May 2016.)
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.6m | Series A | ||
| Total Funding | 000k | ||